elliptinium has been researched along with Soft Tissue Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amiel, JL; Brule, G; Callet, B; Droz, JP; Huertas, D; Le Chevalier, T; Le Pecq, JB; Paoletti, C; Rouesse, J; Sancho-Garnier, H; Tursz, T; Voisin, PM | 1 |
| Rouësse, J; Somers, R; Thomas, D; van Oosterom, A | 1 |
| Amiel, JL; Caille, P; De Jager, R; Le Chevalier, T; May-Levin, F; Mondesir, JM; Rouësse, JG; Sancho-Garnier, H; Spielmann, M | 1 |
3 other study(ies) available for elliptinium and Soft Tissue Neoplasms
| Article | Year |
|---|---|
[N-Methyl-9 hydroxy-ellipticine (NSC 264-137) in the treatment of malignant metastases. Preliminary results (author's transl)].
Topics: Alkaloids; Antineoplastic Agents; Breast Neoplasms; Ellipticines; Hemolysis; Humans; Kidney Neoplasms; Neoplasm Metastasis; Sarcoma; Soft Tissue Neoplasms | 1981 |
Phase II study of elliptinium in metastatic soft tissue sarcoma.
Topics: Adult; Aged; Alkaloids; Drug Evaluation; Ellipticines; Female; Humans; Male; Middle Aged; Sarcoma; Soft Tissue Neoplasms | 1985 |
Phase II study of elliptinium in advanced breast cancer.
Topics: Acute Kidney Injury; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Hemolysis; Humans; Immunoglobulin M; Middle Aged; Soft Tissue Neoplasms | 1985 |